CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-04 | LIPTAK ROBERT Director | Exercise or conversion | +300 | $15.34 | $5K | 26,459 |
| 2016-01-04 | LIPTAK ROBERT Director | Sale | −300 | $27.50 | $8K | 26,159 |
| 2016-01-04 | LIPTAK ROBERT Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −300 | 15,000 | ||
| 2015-11-16 | Murphy A Brett Group President, Commerical Op | Sale | −5,000 | $25.80 | $129K | 116,217 |
| 2015-09-15 | Davidar David D Senior VP, Operations | Gift | −20,000 | 733,775 | ||
| 2015-08-28 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2015-07-07 | Williams Anthony L Senior VP of Bus. Devel. & GC | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2015-07-07 | Murphy A Brett Executive VP, US Sales | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2015-05-28 | Payne Steven Chief Accounting Officer | Exercise or conversion | +3,076 | $11.87 | $37K | 23,847 |
| 2015-05-28 | Payne Steven Chief Accounting Officer | Sale | −3,076 | $25.92 | $80K | 20,771 |
| 2015-05-28 | Payne Steven Chief Accounting Officer | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −3,076 | 0 | ||
| 2015-03-19 | Paul David C Chief Executive Officer | Sale | −494,921 | $25.00 | $12.4M | 1,078,000 |
| 2015-03-18 | Paul David C Chief Executive Officer | Sale | −1,427,079 | $25.00 | $35.7M | 1,572,921 |
| 2015-02-26 | Demski David M President and COO | Sale | −32,510 | $26.00 | $845K | 148,855 |
| 2015-01-20 | Paul David C Chief Executive Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +125,000 | 125,000 | ||
| 2015-01-20 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2015-01-20 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2015-01-20 | Demski David M President and COO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2015-01-20 | Murphy A Brett Executive VP, US Sales | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +50,000 | 50,000 | ||
| 2015-01-20 | Payne Steven Chief Accounting Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +22,500 | 22,500 |
Page 32 of 36 · 710 trades